Skip to main content

Advertisement

Table 1 PRP ratio in PRP + Visipaque270® and PRP + Iopamiron200® at different incubation delays

From: Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro

Incubation Delay (mn) PRP ratio
Visipaque270® (n = 58) Iopamiron200® (n = 69)
5 0.902 ± 0.028 0.916 ± 0.009
10 0.814 ± 0.014 0.905 ± 0.026
15 0.909 ± 0.020 0.910 ± 0.018
20 0.921 ± 0.025 0.894 ± 0.018
30 0.900 ± 0.028 0.923 ± 0.020
  1. NOTE: PRP ratio is defined as the concentration in PRP in the mixture at each incubation delay divided by the initial concentration in PRP. Results are mean ± sd